Global Infliximab Injection Market Growth 2026-2032
The global Infliximab Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Infliximab injection is an antibody drug composed of chimeric monoclonal antibodies. It reduces inflammatory responses by inhibiting the activity of TNF-? and is used to treat a variety of chronic inflammatory diseases.
United States market for Infliximab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Infliximab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Infliximab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Infliximab Injection players cover Celltrion, Janssen Biologics, Hangzhou Bozhirui Biopharmaceuticals, Taizhou Maiboteike Pharmaceuticals, Yuxi Jiahe Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Infliximab Injection Industry Forecast? looks at past sales and reviews total world Infliximab Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Infliximab Injection sales for 2026 through 2032. With Infliximab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infliximab Injection industry.
This Insight Report provides a comprehensive analysis of the global Infliximab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infliximab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Infliximab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infliximab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infliximab Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Infliximab Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Infliximab Injection market?
What factors are driving Infliximab Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infliximab Injection market opportunities vary by end market size?
How does Infliximab Injection break out by Type, by Application?
Infliximab injection is an antibody drug composed of chimeric monoclonal antibodies. It reduces inflammatory responses by inhibiting the activity of TNF-? and is used to treat a variety of chronic inflammatory diseases.
United States market for Infliximab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Infliximab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Infliximab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Infliximab Injection players cover Celltrion, Janssen Biologics, Hangzhou Bozhirui Biopharmaceuticals, Taizhou Maiboteike Pharmaceuticals, Yuxi Jiahe Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Infliximab Injection Industry Forecast? looks at past sales and reviews total world Infliximab Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Infliximab Injection sales for 2026 through 2032. With Infliximab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infliximab Injection industry.
This Insight Report provides a comprehensive analysis of the global Infliximab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infliximab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Infliximab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infliximab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infliximab Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Infliximab Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Original Drug
- Generic Drug
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Celltrion
- Janssen Biologics
- Hangzhou Bozhirui Biopharmaceuticals
- Taizhou Maiboteike Pharmaceuticals
- Yuxi Jiahe Biotechnology
- Ayumi Pharmaceuticals
- Pfizer
- Nichiiko
- Nippon Kayaku
- AMGEN
What is the 10-year outlook for the global Infliximab Injection market?
What factors are driving Infliximab Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infliximab Injection market opportunities vary by end market size?
How does Infliximab Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infliximab Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Infliximab Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Infliximab Injection by Country/Region, 2021, 2025 & 2032
2.2 Infliximab Injection Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 Infliximab Injection Sales by Type
2.2.3.1 Global Infliximab Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Infliximab Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Infliximab Injection Sale Price by Type (2021-2026)
2.3 Infliximab Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Infliximab Injection Sales by Application
2.3.4.1 Global Infliximab Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Infliximab Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Infliximab Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Infliximab Injection Breakdown Data by Company
3.1.1 Global Infliximab Injection Annual Sales by Company (2021-2026)
3.1.2 Global Infliximab Injection Sales Market Share by Company (2021-2026)
3.2 Global Infliximab Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Infliximab Injection Revenue by Company (2021-2026)
3.2.2 Global Infliximab Injection Revenue Market Share by Company (2021-2026)
3.3 Global Infliximab Injection Sale Price by Company
3.4 Key Manufacturers Infliximab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infliximab Injection Product Location Distribution
3.4.2 Players Infliximab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INFLIXIMAB INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Infliximab Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Infliximab Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Infliximab Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Infliximab Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Infliximab Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Infliximab Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Infliximab Injection Sales Growth
4.4 APAC Infliximab Injection Sales Growth
4.5 Europe Infliximab Injection Sales Growth
4.6 Middle East & Africa Infliximab Injection Sales Growth
5 AMERICAS
5.1 Americas Infliximab Injection Sales by Country
5.1.1 Americas Infliximab Injection Sales by Country (2021-2026)
5.1.2 Americas Infliximab Injection Revenue by Country (2021-2026)
5.2 Americas Infliximab Injection Sales by Type (2021-2026)
5.3 Americas Infliximab Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infliximab Injection Sales by Region
6.1.1 APAC Infliximab Injection Sales by Region (2021-2026)
6.1.2 APAC Infliximab Injection Revenue by Region (2021-2026)
6.2 APAC Infliximab Injection Sales by Type (2021-2026)
6.3 APAC Infliximab Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Infliximab Injection by Country
7.1.1 Europe Infliximab Injection Sales by Country (2021-2026)
7.1.2 Europe Infliximab Injection Revenue by Country (2021-2026)
7.2 Europe Infliximab Injection Sales by Type (2021-2026)
7.3 Europe Infliximab Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infliximab Injection by Country
8.1.1 Middle East & Africa Infliximab Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Infliximab Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Infliximab Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Infliximab Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infliximab Injection
10.3 Manufacturing Process Analysis of Infliximab Injection
10.4 Industry Chain Structure of Infliximab Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infliximab Injection Distributors
11.3 Infliximab Injection Customer
12 WORLD FORECAST REVIEW FOR INFLIXIMAB INJECTION BY GEOGRAPHIC REGION
12.1 Global Infliximab Injection Market Size Forecast by Region
12.1.1 Global Infliximab Injection Forecast by Region (2027-2032)
12.1.2 Global Infliximab Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Infliximab Injection Forecast by Type (2027-2032)
12.7 Global Infliximab Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Celltrion
13.1.1 Celltrion Company Information
13.1.2 Celltrion Infliximab Injection Product Portfolios and Specifications
13.1.3 Celltrion Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Celltrion Main Business Overview
13.1.5 Celltrion Latest Developments
13.2 Janssen Biologics
13.2.1 Janssen Biologics Company Information
13.2.2 Janssen Biologics Infliximab Injection Product Portfolios and Specifications
13.2.3 Janssen Biologics Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Janssen Biologics Main Business Overview
13.2.5 Janssen Biologics Latest Developments
13.3 Hangzhou Bozhirui Biopharmaceuticals
13.3.1 Hangzhou Bozhirui Biopharmaceuticals Company Information
13.3.2 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product Portfolios and Specifications
13.3.3 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hangzhou Bozhirui Biopharmaceuticals Main Business Overview
13.3.5 Hangzhou Bozhirui Biopharmaceuticals Latest Developments
13.4 Taizhou Maiboteike Pharmaceuticals
13.4.1 Taizhou Maiboteike Pharmaceuticals Company Information
13.4.2 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product Portfolios and Specifications
13.4.3 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Taizhou Maiboteike Pharmaceuticals Main Business Overview
13.4.5 Taizhou Maiboteike Pharmaceuticals Latest Developments
13.5 Yuxi Jiahe Biotechnology
13.5.1 Yuxi Jiahe Biotechnology Company Information
13.5.2 Yuxi Jiahe Biotechnology Infliximab Injection Product Portfolios and Specifications
13.5.3 Yuxi Jiahe Biotechnology Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yuxi Jiahe Biotechnology Main Business Overview
13.5.5 Yuxi Jiahe Biotechnology Latest Developments
13.6 Ayumi Pharmaceuticals
13.6.1 Ayumi Pharmaceuticals Company Information
13.6.2 Ayumi Pharmaceuticals Infliximab Injection Product Portfolios and Specifications
13.6.3 Ayumi Pharmaceuticals Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Ayumi Pharmaceuticals Main Business Overview
13.6.5 Ayumi Pharmaceuticals Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Infliximab Injection Product Portfolios and Specifications
13.7.3 Pfizer Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Nichiiko
13.8.1 Nichiiko Company Information
13.8.2 Nichiiko Infliximab Injection Product Portfolios and Specifications
13.8.3 Nichiiko Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Nichiiko Main Business Overview
13.8.5 Nichiiko Latest Developments
13.9 Nippon Kayaku
13.9.1 Nippon Kayaku Company Information
13.9.2 Nippon Kayaku Infliximab Injection Product Portfolios and Specifications
13.9.3 Nippon Kayaku Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Nippon Kayaku Main Business Overview
13.9.5 Nippon Kayaku Latest Developments
13.10 AMGEN
13.10.1 AMGEN Company Information
13.10.2 AMGEN Infliximab Injection Product Portfolios and Specifications
13.10.3 AMGEN Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 AMGEN Main Business Overview
13.10.5 AMGEN Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infliximab Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Infliximab Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Infliximab Injection by Country/Region, 2021, 2025 & 2032
2.2 Infliximab Injection Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 Infliximab Injection Sales by Type
2.2.3.1 Global Infliximab Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Infliximab Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Infliximab Injection Sale Price by Type (2021-2026)
2.3 Infliximab Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Infliximab Injection Sales by Application
2.3.4.1 Global Infliximab Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Infliximab Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Infliximab Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Infliximab Injection Breakdown Data by Company
3.1.1 Global Infliximab Injection Annual Sales by Company (2021-2026)
3.1.2 Global Infliximab Injection Sales Market Share by Company (2021-2026)
3.2 Global Infliximab Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Infliximab Injection Revenue by Company (2021-2026)
3.2.2 Global Infliximab Injection Revenue Market Share by Company (2021-2026)
3.3 Global Infliximab Injection Sale Price by Company
3.4 Key Manufacturers Infliximab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infliximab Injection Product Location Distribution
3.4.2 Players Infliximab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INFLIXIMAB INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Infliximab Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Infliximab Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Infliximab Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Infliximab Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Infliximab Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Infliximab Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Infliximab Injection Sales Growth
4.4 APAC Infliximab Injection Sales Growth
4.5 Europe Infliximab Injection Sales Growth
4.6 Middle East & Africa Infliximab Injection Sales Growth
5 AMERICAS
5.1 Americas Infliximab Injection Sales by Country
5.1.1 Americas Infliximab Injection Sales by Country (2021-2026)
5.1.2 Americas Infliximab Injection Revenue by Country (2021-2026)
5.2 Americas Infliximab Injection Sales by Type (2021-2026)
5.3 Americas Infliximab Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infliximab Injection Sales by Region
6.1.1 APAC Infliximab Injection Sales by Region (2021-2026)
6.1.2 APAC Infliximab Injection Revenue by Region (2021-2026)
6.2 APAC Infliximab Injection Sales by Type (2021-2026)
6.3 APAC Infliximab Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Infliximab Injection by Country
7.1.1 Europe Infliximab Injection Sales by Country (2021-2026)
7.1.2 Europe Infliximab Injection Revenue by Country (2021-2026)
7.2 Europe Infliximab Injection Sales by Type (2021-2026)
7.3 Europe Infliximab Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infliximab Injection by Country
8.1.1 Middle East & Africa Infliximab Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Infliximab Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Infliximab Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Infliximab Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infliximab Injection
10.3 Manufacturing Process Analysis of Infliximab Injection
10.4 Industry Chain Structure of Infliximab Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infliximab Injection Distributors
11.3 Infliximab Injection Customer
12 WORLD FORECAST REVIEW FOR INFLIXIMAB INJECTION BY GEOGRAPHIC REGION
12.1 Global Infliximab Injection Market Size Forecast by Region
12.1.1 Global Infliximab Injection Forecast by Region (2027-2032)
12.1.2 Global Infliximab Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Infliximab Injection Forecast by Type (2027-2032)
12.7 Global Infliximab Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Celltrion
13.1.1 Celltrion Company Information
13.1.2 Celltrion Infliximab Injection Product Portfolios and Specifications
13.1.3 Celltrion Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Celltrion Main Business Overview
13.1.5 Celltrion Latest Developments
13.2 Janssen Biologics
13.2.1 Janssen Biologics Company Information
13.2.2 Janssen Biologics Infliximab Injection Product Portfolios and Specifications
13.2.3 Janssen Biologics Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Janssen Biologics Main Business Overview
13.2.5 Janssen Biologics Latest Developments
13.3 Hangzhou Bozhirui Biopharmaceuticals
13.3.1 Hangzhou Bozhirui Biopharmaceuticals Company Information
13.3.2 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product Portfolios and Specifications
13.3.3 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hangzhou Bozhirui Biopharmaceuticals Main Business Overview
13.3.5 Hangzhou Bozhirui Biopharmaceuticals Latest Developments
13.4 Taizhou Maiboteike Pharmaceuticals
13.4.1 Taizhou Maiboteike Pharmaceuticals Company Information
13.4.2 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product Portfolios and Specifications
13.4.3 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Taizhou Maiboteike Pharmaceuticals Main Business Overview
13.4.5 Taizhou Maiboteike Pharmaceuticals Latest Developments
13.5 Yuxi Jiahe Biotechnology
13.5.1 Yuxi Jiahe Biotechnology Company Information
13.5.2 Yuxi Jiahe Biotechnology Infliximab Injection Product Portfolios and Specifications
13.5.3 Yuxi Jiahe Biotechnology Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yuxi Jiahe Biotechnology Main Business Overview
13.5.5 Yuxi Jiahe Biotechnology Latest Developments
13.6 Ayumi Pharmaceuticals
13.6.1 Ayumi Pharmaceuticals Company Information
13.6.2 Ayumi Pharmaceuticals Infliximab Injection Product Portfolios and Specifications
13.6.3 Ayumi Pharmaceuticals Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Ayumi Pharmaceuticals Main Business Overview
13.6.5 Ayumi Pharmaceuticals Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Infliximab Injection Product Portfolios and Specifications
13.7.3 Pfizer Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Nichiiko
13.8.1 Nichiiko Company Information
13.8.2 Nichiiko Infliximab Injection Product Portfolios and Specifications
13.8.3 Nichiiko Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Nichiiko Main Business Overview
13.8.5 Nichiiko Latest Developments
13.9 Nippon Kayaku
13.9.1 Nippon Kayaku Company Information
13.9.2 Nippon Kayaku Infliximab Injection Product Portfolios and Specifications
13.9.3 Nippon Kayaku Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Nippon Kayaku Main Business Overview
13.9.5 Nippon Kayaku Latest Developments
13.10 AMGEN
13.10.1 AMGEN Company Information
13.10.2 AMGEN Infliximab Injection Product Portfolios and Specifications
13.10.3 AMGEN Infliximab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 AMGEN Main Business Overview
13.10.5 AMGEN Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Infliximab Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Infliximab Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global Infliximab Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Infliximab Injection Sales Market Share by Type (2021-2026)
Table 7. Global Infliximab Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Infliximab Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Infliximab Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Infliximab Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Infliximab Injection Sale Market Share by Application (2021-2026)
Table 12. Global Infliximab Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Infliximab Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Infliximab Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Infliximab Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Infliximab Injection Sales Market Share by Company (2021-2026)
Table 17. Global Infliximab Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Infliximab Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Infliximab Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Infliximab Injection Producing Area Distribution and Sales Area
Table 21. Players Infliximab Injection Products Offered
Table 22. Infliximab Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Infliximab Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Infliximab Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Infliximab Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Infliximab Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Infliximab Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Infliximab Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Infliximab Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Infliximab Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Infliximab Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Infliximab Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Infliximab Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Infliximab Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Infliximab Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Infliximab Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Infliximab Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Infliximab Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Infliximab Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Infliximab Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Infliximab Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Infliximab Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Infliximab Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Infliximab Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Infliximab Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Infliximab Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Infliximab Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Infliximab Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Infliximab Injection
Table 52. Key Market Challenges & Risks of Infliximab Injection
Table 53. Key Industry Trends of Infliximab Injection
Table 54. Infliximab Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Infliximab Injection Distributors List
Table 57. Infliximab Injection Customer List
Table 58. Global Infliximab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Infliximab Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Infliximab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Infliximab Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Infliximab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Infliximab Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Infliximab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Infliximab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Infliximab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Infliximab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Infliximab Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Infliximab Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Infliximab Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Infliximab Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Celltrion Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Celltrion Infliximab Injection Product Portfolios and Specifications
Table 74. Celltrion Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Celltrion Main Business
Table 76. Celltrion Latest Developments
Table 77. Janssen Biologics Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Janssen Biologics Infliximab Injection Product Portfolios and Specifications
Table 79. Janssen Biologics Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Janssen Biologics Main Business
Table 81. Janssen Biologics Latest Developments
Table 82. Hangzhou Bozhirui Biopharmaceuticals Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product Portfolios and Specifications
Table 84. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Hangzhou Bozhirui Biopharmaceuticals Main Business
Table 86. Hangzhou Bozhirui Biopharmaceuticals Latest Developments
Table 87. Taizhou Maiboteike Pharmaceuticals Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product Portfolios and Specifications
Table 89. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Taizhou Maiboteike Pharmaceuticals Main Business
Table 91. Taizhou Maiboteike Pharmaceuticals Latest Developments
Table 92. Yuxi Jiahe Biotechnology Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Yuxi Jiahe Biotechnology Infliximab Injection Product Portfolios and Specifications
Table 94. Yuxi Jiahe Biotechnology Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Yuxi Jiahe Biotechnology Main Business
Table 96. Yuxi Jiahe Biotechnology Latest Developments
Table 97. Ayumi Pharmaceuticals Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Ayumi Pharmaceuticals Infliximab Injection Product Portfolios and Specifications
Table 99. Ayumi Pharmaceuticals Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Ayumi Pharmaceuticals Main Business
Table 101. Ayumi Pharmaceuticals Latest Developments
Table 102. Pfizer Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Pfizer Infliximab Injection Product Portfolios and Specifications
Table 104. Pfizer Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Pfizer Main Business
Table 106. Pfizer Latest Developments
Table 107. Nichiiko Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Nichiiko Infliximab Injection Product Portfolios and Specifications
Table 109. Nichiiko Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Nichiiko Main Business
Table 111. Nichiiko Latest Developments
Table 112. Nippon Kayaku Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Nippon Kayaku Infliximab Injection Product Portfolios and Specifications
Table 114. Nippon Kayaku Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Nippon Kayaku Main Business
Table 116. Nippon Kayaku Latest Developments
Table 117. AMGEN Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. AMGEN Infliximab Injection Product Portfolios and Specifications
Table 119. AMGEN Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. AMGEN Main Business
Table 121. AMGEN Latest Developments
Table 1. Infliximab Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Infliximab Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global Infliximab Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Infliximab Injection Sales Market Share by Type (2021-2026)
Table 7. Global Infliximab Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Infliximab Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Infliximab Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Infliximab Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Infliximab Injection Sale Market Share by Application (2021-2026)
Table 12. Global Infliximab Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Infliximab Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Infliximab Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Infliximab Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Infliximab Injection Sales Market Share by Company (2021-2026)
Table 17. Global Infliximab Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Infliximab Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Infliximab Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Infliximab Injection Producing Area Distribution and Sales Area
Table 21. Players Infliximab Injection Products Offered
Table 22. Infliximab Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Infliximab Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Infliximab Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Infliximab Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Infliximab Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Infliximab Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Infliximab Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Infliximab Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Infliximab Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Infliximab Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Infliximab Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Infliximab Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Infliximab Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Infliximab Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Infliximab Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Infliximab Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Infliximab Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Infliximab Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Infliximab Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Infliximab Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Infliximab Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Infliximab Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Infliximab Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Infliximab Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Infliximab Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Infliximab Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Infliximab Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Infliximab Injection
Table 52. Key Market Challenges & Risks of Infliximab Injection
Table 53. Key Industry Trends of Infliximab Injection
Table 54. Infliximab Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Infliximab Injection Distributors List
Table 57. Infliximab Injection Customer List
Table 58. Global Infliximab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Infliximab Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Infliximab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Infliximab Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Infliximab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Infliximab Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Infliximab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Infliximab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Infliximab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Infliximab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Infliximab Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Infliximab Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Infliximab Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Infliximab Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Celltrion Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Celltrion Infliximab Injection Product Portfolios and Specifications
Table 74. Celltrion Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Celltrion Main Business
Table 76. Celltrion Latest Developments
Table 77. Janssen Biologics Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Janssen Biologics Infliximab Injection Product Portfolios and Specifications
Table 79. Janssen Biologics Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Janssen Biologics Main Business
Table 81. Janssen Biologics Latest Developments
Table 82. Hangzhou Bozhirui Biopharmaceuticals Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product Portfolios and Specifications
Table 84. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Hangzhou Bozhirui Biopharmaceuticals Main Business
Table 86. Hangzhou Bozhirui Biopharmaceuticals Latest Developments
Table 87. Taizhou Maiboteike Pharmaceuticals Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product Portfolios and Specifications
Table 89. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Taizhou Maiboteike Pharmaceuticals Main Business
Table 91. Taizhou Maiboteike Pharmaceuticals Latest Developments
Table 92. Yuxi Jiahe Biotechnology Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Yuxi Jiahe Biotechnology Infliximab Injection Product Portfolios and Specifications
Table 94. Yuxi Jiahe Biotechnology Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Yuxi Jiahe Biotechnology Main Business
Table 96. Yuxi Jiahe Biotechnology Latest Developments
Table 97. Ayumi Pharmaceuticals Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Ayumi Pharmaceuticals Infliximab Injection Product Portfolios and Specifications
Table 99. Ayumi Pharmaceuticals Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Ayumi Pharmaceuticals Main Business
Table 101. Ayumi Pharmaceuticals Latest Developments
Table 102. Pfizer Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Pfizer Infliximab Injection Product Portfolios and Specifications
Table 104. Pfizer Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Pfizer Main Business
Table 106. Pfizer Latest Developments
Table 107. Nichiiko Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Nichiiko Infliximab Injection Product Portfolios and Specifications
Table 109. Nichiiko Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Nichiiko Main Business
Table 111. Nichiiko Latest Developments
Table 112. Nippon Kayaku Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Nippon Kayaku Infliximab Injection Product Portfolios and Specifications
Table 114. Nippon Kayaku Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Nippon Kayaku Main Business
Table 116. Nippon Kayaku Latest Developments
Table 117. AMGEN Basic Information, Infliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. AMGEN Infliximab Injection Product Portfolios and Specifications
Table 119. AMGEN Infliximab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. AMGEN Main Business
Table 121. AMGEN Latest Developments
LIST OF FIGURES
Figure 1. Picture of Infliximab Injection
Figure 2. Infliximab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Infliximab Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Infliximab Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Infliximab Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Infliximab Injection Sales Market Share by Country/Region (2025)
Figure 10. Infliximab Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Generic Drug
Figure 13. Global Infliximab Injection Sales Market Share by Type in 2026
Figure 14. Global Infliximab Injection Revenue Market Share by Type (2021-2026)
Figure 15. Infliximab Injection Consumed in Hospital
Figure 16. Global Infliximab Injection Market: Hospital (2021-2026) & (K Units)
Figure 17. Infliximab Injection Consumed in Clinic
Figure 18. Global Infliximab Injection Market: Clinic (2021-2026) & (K Units)
Figure 19. Infliximab Injection Consumed in Other
Figure 20. Global Infliximab Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Infliximab Injection Sale Market Share by Application (2025)
Figure 22. Global Infliximab Injection Revenue Market Share by Application in 2026
Figure 23. Infliximab Injection Sales by Company in 2026 (K Units)
Figure 24. Global Infliximab Injection Sales Market Share by Company in 2026
Figure 25. Infliximab Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Infliximab Injection Revenue Market Share by Company in 2026
Figure 27. Global Infliximab Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Infliximab Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Infliximab Injection Sales 2021-2026 (K Units)
Figure 30. Americas Infliximab Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Infliximab Injection Sales 2021-2026 (K Units)
Figure 32. APAC Infliximab Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Infliximab Injection Sales 2021-2026 (K Units)
Figure 34. Europe Infliximab Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Infliximab Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Infliximab Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Infliximab Injection Sales Market Share by Country in 2026
Figure 38. Americas Infliximab Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Infliximab Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Infliximab Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Infliximab Injection Sales Market Share by Region in 2026
Figure 46. APAC Infliximab Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Infliximab Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Infliximab Injection Sales Market Share by Application (2021-2026)
Figure 49. China Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Infliximab Injection Sales Market Share by Country in 2026
Figure 57. Europe Infliximab Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Infliximab Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Infliximab Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Infliximab Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Infliximab Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Infliximab Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Infliximab Injection in 2026
Figure 74. Manufacturing Process Analysis of Infliximab Injection
Figure 75. Industry Chain Structure of Infliximab Injection
Figure 76. Channels of Distribution
Figure 77. Global Infliximab Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Infliximab Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Infliximab Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Infliximab Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Infliximab Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Infliximab Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Infliximab Injection
Figure 2. Infliximab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Infliximab Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Infliximab Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Infliximab Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Infliximab Injection Sales Market Share by Country/Region (2025)
Figure 10. Infliximab Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Generic Drug
Figure 13. Global Infliximab Injection Sales Market Share by Type in 2026
Figure 14. Global Infliximab Injection Revenue Market Share by Type (2021-2026)
Figure 15. Infliximab Injection Consumed in Hospital
Figure 16. Global Infliximab Injection Market: Hospital (2021-2026) & (K Units)
Figure 17. Infliximab Injection Consumed in Clinic
Figure 18. Global Infliximab Injection Market: Clinic (2021-2026) & (K Units)
Figure 19. Infliximab Injection Consumed in Other
Figure 20. Global Infliximab Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Infliximab Injection Sale Market Share by Application (2025)
Figure 22. Global Infliximab Injection Revenue Market Share by Application in 2026
Figure 23. Infliximab Injection Sales by Company in 2026 (K Units)
Figure 24. Global Infliximab Injection Sales Market Share by Company in 2026
Figure 25. Infliximab Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Infliximab Injection Revenue Market Share by Company in 2026
Figure 27. Global Infliximab Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Infliximab Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Infliximab Injection Sales 2021-2026 (K Units)
Figure 30. Americas Infliximab Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Infliximab Injection Sales 2021-2026 (K Units)
Figure 32. APAC Infliximab Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Infliximab Injection Sales 2021-2026 (K Units)
Figure 34. Europe Infliximab Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Infliximab Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Infliximab Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Infliximab Injection Sales Market Share by Country in 2026
Figure 38. Americas Infliximab Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Infliximab Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Infliximab Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Infliximab Injection Sales Market Share by Region in 2026
Figure 46. APAC Infliximab Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Infliximab Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Infliximab Injection Sales Market Share by Application (2021-2026)
Figure 49. China Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Infliximab Injection Sales Market Share by Country in 2026
Figure 57. Europe Infliximab Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Infliximab Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Infliximab Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Infliximab Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Infliximab Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Infliximab Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Infliximab Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Infliximab Injection in 2026
Figure 74. Manufacturing Process Analysis of Infliximab Injection
Figure 75. Industry Chain Structure of Infliximab Injection
Figure 76. Channels of Distribution
Figure 77. Global Infliximab Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Infliximab Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Infliximab Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Infliximab Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Infliximab Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Infliximab Injection Revenue Market Share Forecast by Application (2027-2032)
